INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

QCLSQ/C TECHNOLOGIES, INC.

CIK 0001321834

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score21
Connections7with evidence

QCLS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
SJ
Silverman JoshuaDirector, Executive Chairman
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
162.2K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2835 · In Vitro & In Vivo Diagnostic Substances · Nov 4, 2026
  • ← Insider ofevidence
    Voss Chelsea SierraDirector · Apr 15, 2026
  • ← Insider ofevidence
    Silverman JoshuaDirector, Executive Chairman · Apr 15, 2026
  • ← Insider ofevidence
    White Billy JoeDirector · Apr 15, 2026
9
SJ
Silverman JoshuaDirector, Executive Chairman
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A
—
100.0K sh
Apr 13, 2026
Apr 15, 2026
traded Apr 13, 2026
+2d
SEC FORM 4

Evidence

9
GM
Glass MitchellDirector, Chief Medical Officer
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
FS
Friscia StephenDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
WJ
White Billy JoeDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
BB
Bernstein BruceDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
VS
Voss Chelsea SierraDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Friscia StephenDirector · Apr 15, 2026
  • ← Insider ofevidence
    Bernstein BruceDirector · Apr 15, 2026
  • ← Insider ofevidence
    Glass MitchellDirector, Chief Medical Officer · Apr 15, 2026